Hepatobiliary & Pancreatic Diseases International

Papers
(The H4-Index of Hepatobiliary & Pancreatic Diseases International is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas mimicking pancreatic pseudocyst43
Primary pancreatic lymphoma diagnosed by endoscopic ultrasound-guided fine needle biopsy40
Relevant content40
Inadvertent perioperative hypothermia and surgical site infections after liver resection38
Advances and current research status of early diagnosis for gallbladder cancer36
Laparoscopic extended right hepatectomy for posterior and completely caudate massive liver tumor (with videos)34
Meetings and Courses34
Impact of metabolic disorders on gallstone disease and perioperative recovery after laparoscopic cholecystectomy33
CK2α causes stemness and chemotherapy resistance in liver cancer through the Hedgehog signaling pathway33
Application of extended criteria donor liver grafts in liver transplantation30
Liver transplantation as an alternative for the treatment of neuroendocrine liver metastasis: Appraisal of the current evidence29
Pre-MASLD: Should it be defined separately?28
Palmar metastasis of hepatocellular carcinoma: An uncommon case report25
Post-hepatectomy liver failure: A timeline centered review22
Cryptococcosis in patients with liver cirrhosis: Death risk factors and predictive value of prognostic models22
Key factors and potential drug combinations of nonalcoholic steatohepatitis: Bioinformatic analysis and experimental validation-based study21
Oncogenic Wnt3a is a promising sensitive biomarker for monitoring hepatocarcinogenesis19
The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional s19
Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure19
Minimizing the risk of small-for-size syndrome after liver surgery19
0.036693811416626